Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;39(6):1116-1122.
doi: 10.5114/ada.2022.122606. Epub 2022 Dec 22.

308-nm excimer lamp with 0.03% tacrolimus ointment is safe and effective to treat children with non-segmental vitiligo

Affiliations

308-nm excimer lamp with 0.03% tacrolimus ointment is safe and effective to treat children with non-segmental vitiligo

Peishan Li et al. Postepy Dermatol Alergol. 2022 Dec.

Abstract

Introduction: A 308-nm excimer lamp combined with topical medicines has been used to treat vitiligo. However, few studies have evaluated its efficacy and influencing factors in children.

Aim: We investigated the clinical effects and factors influencing the effectiveness of a 308-nm excimer lamp combined with 0.03% tacrolimus ointment in treating children with non-segmental vitiligo.

Material and methods: A retrospective interventional case-series study was performed on 73 patients with non-segmental vitiligo treated with combination therapy. The duration of treatment ranged from 1 to 24 months, and the total number of treatments ranged from 4 to 78 sessions. We evaluated different treatment factors, including the number of treatments with a 308-nm excimer lamp, location, dose, disease course, and adverse reactions.

Results: Overall, 105 leukodermas were treated: 36.2% had disappeared completely. The efficiency rate was 81.9% after a median treatment duration of 10.5 months. The treatment was most effective for the face and neck. Patients with a short disease duration showed a better response (disease duration shorter than 12 months). Reported adverse reactions were mild.

Conclusions: Treatment using a 308-nm excimer lamp and 0.03% tacrolimus ointment is a safe and valuable treatment for children with non-segmental vitiligo.

Keywords: drug reaction; phototherapy; tacrolimus; vitiligo.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
A – Patient showing a vitiligo lesion on the neck before the excimer lamp treatment. B – The same patient showing that the skin had returned to its normal colour after two courses of treatment. C – Patient showing multiple vitiligo lesions on the neck before the excimer lamp treatment. D – The same patient showing significant improvement after two courses of treatment. E – Patient showing a vitiligo lesion on the face before the excimer lamp treatment. F – The same patient showing partial improvement after two courses of treatment. G – Patient showing a vitiligo lesion on the foot before the excimer lamp treatment. H – The same patient showing no improvement with expansion of the affected area after two courses of treatment

Similar articles

Cited by

References

    1. Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol 2012; 51: 1206-12. - PubMed
    1. Frisoli ML, Harris JE. Vitiligo: mechanistic insights lead to novel treatments. J Allergy Clin Immunol 2017; 140: 654-62. - PubMed
    1. Wańkowicz-Kalińska A, van den Wijngaard RM, Tigges BJ, et al. . Immunopolarization of CD4+ and CD8+ T cells to type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest 2003; 83: 683-95. - PubMed
    1. van den Boorn JG, Konijnenberg D, Dellemijn TA, et al. . Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 2009; 129: 2220-32. - PubMed
    1. Novák Z, Bónis B, Baltás E, et al. . Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B. J Photochem Photobiol B 2002; 67: 32-8. - PubMed